本页面由Tiger Trade Technology Pte. Ltd.提供服务

阿尔尼拉姆制药公司

227.02
-5.6600-2.43%
盘后:226.00-1.0200-0.45%19:59 EDT
成交量:91.69万
成交额:2.10亿
市值:302.91亿
市盈率:40.40
高:233.60
开:233.13
低:226.35
收:232.68
52周最高:495.55
52周最低:197.81
股本:1.33亿
流通股本:1.33亿
量比:0.71
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):5.62
每股收益(LYR):2.33
净资产收益率:96.55%
总资产收益率:12.34%
市净率:22.37
市盈率(LYR):97.43

数据加载中...

2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/08/22

SEC问询函

Form CORRESP - Correspondence
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities